drugset / Trial / NCT07082855
A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, double-blind, randomized controlled clinical trial to get high - level evidence on minocycline's efficacy and safety（100mg/d, 200mg/d) for Retinitis pigmentosa and to find the optimal treatment dose.
Timeline
- Start
- 2025-07-15
- Primary completion
- 2028-02-28
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 100 mg | Oral |
| Subject | Minocycline | Small molecule | 200 mg | Oral |